rivaroxaban

The medicine is used in adults to treat blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), as well as to prevent the recurrence of such clots.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Lek Pharmaceuticals d.d. PharOS Mt Ltd Rontis Hellas Medical and Pharmaceutical Products S.A.

In adults, it is used to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used for the treatment and prevention of blood clots in the veins or lungs following initial treatment with injections.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Lek Pharmaceuticals d.d. PharOS Mt Ltd Rontis Hellas Medical and Pharmaceutical Products S.A.

The medicine is used in adults to reduce the risk of another heart attack or to reduce the risk of death from cardiovascular disease (e.g., after acute coronary syndrome). It is also used to reduce the risk of blood clots in people at high risk due to coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Pharmadox Healthcare Ltd., S.C. Zentiva S.A.

Xanirva is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Pharmadox Healthcare Ltd., S.C. Zentiva S.A.

Xanirva is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent the recurrence of blood clots in the veins of the legs or lungs. In children and adolescents (over 30 kg), it is also used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Pharmadox Healthcare Ltd., S.C. Zentiva S.A.

Xanirva is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and lungs. In children and adolescents (weighing over 30 kg), it is also used to treat clots following initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Pharmadox Healthcare Ltd., S.C. Zentiva S.A.

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Form: capsules, hard

ATC: B01AF01

Manufacturer: Pharmadox Healthcare Ltd., Zentiva SA

In adults, it is used to prevent strokes and other blood clots (in atrial fibrillation) and to treat and prevent clots in the leg veins and pulmonary vessels. In children and adolescents (over 30 kg), it is used to treat and prevent clots in the veins or lungs following initial treatment with injectable medications.

Form: capsules, hard

ATC: B01AF01

Manufacturer: Pharmadox Healthcare Ltd., Zentiva SA

Xanirva is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat and prevent blood clots in the veins or lungs following initial treatment with injections.

Form: capsules, hard

ATC: B01AF01

Manufacturer: Pharmadox Healthcare Ltd., Zentiva SA

This medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery. It is also used to treat deep vein thrombosis and pulmonary embolism, as well as to prevent the recurrence of blood clots in the blood vessels of the legs and lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH

The medicine is used in adults to prevent strokes and other blood clots in the blood vessels in atrial fibrillation, and to treat and prevent deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is also used to treat blood clots in the veins and lungs after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH

Xerdoxo is used in adults to prevent strokes and other blood clots (in atrial fibrillation) and to treat and prevent deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is also used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH

The medicine is used in adults to reduce the risk of another heart attack or death from cardiovascular disease (after acute coronary syndrome) and to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Egis Pharmaceuticals PLC

The medicine is used in adults to prevent blood clots in the veins after hip or knee replacement surgery, and for the treatment and prevention of recurrence of deep vein thrombosis and pulmonary embolism.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Egis Pharmaceuticals PLC

The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used for the treatment and prevention of clots in the veins or lungs following initial treatment with injectable medicines.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Egis Pharmaceuticals PLC

Xiltess is used in adults to prevent strokes and other blood clots (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used to treat and prevent blood clots in the veins or lungs following initial treatment with injectable medications.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Egis Pharmaceuticals PLC

ZARIXA is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg and lung veins. In children and adolescents (weighing more than 30 kg), it is used to treat and prevent blood clots in the veins or lungs following initial injectable treatment.

Form: capsules, hard

ATC: B01AF01

Manufacturer: Celon Pharma S.A.

The medicine is used in adults to prevent strokes and other blood clots (in atrial fibrillation), as well as to treat and prevent clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat and prevent clots in the veins or lungs following initial injectable treatment.

Form: capsules, hard

ATC: B01AF01

Manufacturer: Celon Pharma S.A.

ZARIXA is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, to treat deep vein thrombosis and pulmonary embolism, and to prevent their recurrence.

Form: capsules, hard

ATC: B01AF01

Manufacturer: Celon Pharma S.A.

ZARIXA is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: capsules, hard

ATC: B01AF01

Manufacturer: Celon Pharma S.A.